🇺🇸 FDA

Company profile · Sponsor

Acurx

Acurx Pharmaceuticals

ACXP · NYSE pharma STATEN ISLAND, NY, USA
Pipeline
2
Drugs
0
Patents
8

Quick answer

Acurx (ACXP) is a pharma company. headquartered in STATEN ISLAND, NY, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker ACXP
Exchange NYSE
Company type pharma
Headquarters STATEN ISLAND, NY, USA
SEC CIK 0001736243

Pipeline (2)

Search pipeline →

  1. Ibezapolstat

    Acurx

    Clostridium Difficile Infection

    phase 2 small molecule completed

    1 trial

  2. Ibezapolstat

    Acurx

    Clostridium Difficile Infection Recurrence

    phase 2 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 12036225

    Use of ibezapolstat to promote microbiome health

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11857629

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11723885

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11554114

    Methods and compositions for self-regulated release of active pharmaceutical ingredients

    Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11197837

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11103581

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11083794

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11001592

    DNA polymerase IIIC inhibitors and use thereof

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Acurx?

Acurx (ACXP) is a pharma company. headquartered in STATEN ISLAND, NY, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Acurx sponsor?

We track 2 ClinicalTrials.gov-linked programs for Acurx, including Ibezapolstat and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Acurx company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.